Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saireito for prevention of early high-output stoma after temporary ileostomy in ulcerative colitis surgery
jRCT1041260162Recruiting
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of saireito in autoimmune colitis. Primary endpoint: Incidence of early high-output stoma within 21 days after surgery. Started Nov 2026; status: recruiting.
02
Drugs
saireito
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCT1041260162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041260162.